Skeletal Disorder TRIZ Cases
- Antibodies Inhibiting QSOX1 to Block Laminin Assembly
Monoclonal antibodies target the QSOX1 enzyme to disrupt laminin assembly, addressing the lack of effective agents for treating metastatic solid tumors.
- Biocomposite Dental Implant Material for Bone Integration
A biodegradable polymer composite with beta-tricalcium phosphate granules accelerates bone integration through osteoinduction.
- Recombinant Gelatin Cell Support for Uniform Bone Regeneration
A recombinant gelatin porous body distributes and retains cells uniformly, resolving nonuniform therapeutic effects in bone regeneration scaffolds.
- ITIH4 Citrullination Detection for Rheumatoid Arthritis Diagnosis
Targeting specific ITIH4 arginine residues resolves the sensitivity versus specificity trade-off in anti-CCP testing, ensuring accurate RA disease monitoring.
- Osteopontin Biomarker Monitoring for Scoliosis Risk Detection
Tracking osteopontin biomarkers enables early identification of scoliosis risk, preventing treatment delays caused by late structural detection.
- Spherical Bioactive Glass for Controlled Ion Release
Substantially spherical bioactive glass particles enable controlled ion release profiles.
- Type III Anti-CD20 Antibodies for B-Cell Malignancies
Type III anti-CD20 antibodies overcome resistance by merging CDC, ADCC, and pro-apoptotic activities into a single agent.
- Oral Hyaluronic Acid and Dermatan Sulfate Composition for Osteoarthritis
Oral composition of hyaluronic acid and dermatan sulfate replaces invasive injections to improve joint mobility.
- Lactic Acid Disc Injection for Herniation Treatment
Lactic acid injection dehydrates the nucleus pulposus to reduce disc pressure, avoiding surgical complications.
- TDO2 IDO1 Inhibitors for Fibroid Treatment
Targeting kynurenine pathway enzymes reduces fibroid volume and bleeding while avoiding hormonal side effects.
- Three-Dimensional Stem Cell Spheres for Arthritis Cartilage Repair
Three-dimensional stem cell spheres delay cartilage degradation by regenerating tissue, avoiding surgical replacement limitations.
- Humanized Antibodies Against CEACAM1 with Framework Back-Mutations
Framework back-mutations restore CDR conformation in humanized antibodies, resolving the immunogenicity versus binding affinity trade-off.
- OXY133 Derivative Synthesis via Single-Container Organometallic Reaction
A single-container organometallic reaction synthesizes OXY133 therapeutic agent derivatives with high yield and process safety.
- Anti-Cx43 Antibody for Osteoarthritis Cartilage Protection
Blocking Cx43 hemichannels with an antibody suppresses inflammatory cascades, preserving cartilage integrity and delaying osteoarthritis progression.
- Thiol-Vinyl Adhesive Patch for Bone Fracture Fixation
A thiol-vinyl adhesive patch cures into a solid, biocompatible structure to stabilize bone fractures through chemical bonding.
- Gingival Fibroblast Product for Orthopedic Pathology Treatment
A gingival fibroblast-derived product inhibits matrix metalloproteinase activity to treat musculoskeletal tissue degradation.